PA
VG

PharVision Advisers’s Venture Global Inc VG Stock Holding History

PharVision Advisers’s Portfolio VG Stock Details VG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,901
Closed -$272K – 674
2025
Q4 		$272K Buy
39,901
+27,081
+211% +$226K 0.14% 335
2025
Q3 		$182K Buy
+12,820
New +$183K 0.1% 535

Other funds holding VG

Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

PharVision Advisers's VG Position: Q1 2026 in Review

PharVision Advisers sold out of Venture Global Inc (VG) in Q1 2026, closing a stake of 39,901 shares — an estimated $272K sold.

PharVision Advisers first reported a position in VG in Q3 2025 and held it in 2 quarters. The position peaked at $272K in Q4 2025. 333 funds tracked by Wall St. Rank hold VG as of Q1 2026.

  • PharVision Advisers reported no remaining Venture Global Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 39,901 Venture Global Inc shares in Q1 2026, an estimated $272K.
  • PharVision Advisers first reported a position in Venture Global Inc in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Venture Global Inc position peaked at $272K in Q4 2025.
  • 333 funds tracked by Wall St. Rank held Venture Global Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.